Literature DB >> 17243258

Non-estrogen treatments for osteoporosis: an evidence-based review.

Reamer L Bushardt1, Jennifer L Turner, Kelly R Ragucci, David G Askins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17243258     DOI： 10.1097/01720610-200612000-00006

Source DB:  PubMed          Journal:  JAAPA        ISSN： 0893-7400


× No keyword cloud information.
  4 in total

1.  Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.

Authors:  Lindsay M Coe; Srinivasan Arjun Tekalur; Yutian Shu; Melissa J Baumann; Laura R McCabe
Journal:  J Cell Physiol       Date:  2015-08       Impact factor: 6.384

Review 2.  What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?

Authors:  P D Miller; R J Derman
Journal:  Osteoporos Int       Date:  2010-03-23       Impact factor: 4.507

Review 3.  Efficacy and safety of bazedoxifene for postmenopausal osteoporosis.

Authors:  Hisaya Kawate; Ryoichi Takayanagi
Journal:  Clin Interv Aging       Date:  2011-06-21       Impact factor: 4.458

4.  Alendronate promotes osteoblast differentiation and bone formation in ovariectomy-induced osteoporosis through interferon-β/signal transducer and activator of transcription 1 pathway.

Authors:  Xiaoqing Ma; Zhongyang Xu; Shaofeng Ding; Guangkun Yi; Qian Wang
Journal:  Exp Ther Med       Date:  2017-10-27       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.